Notice

Permit for use of Syvazul BTV3 bluetongue serotype 3 vaccine in the UK

Defra’s Secretary of State has permitted the use of this bluetongue serotype 3 (BTV-3) vaccine within the United Kingdom, subject to licence.

• From: Department for Environment, Food & Rural Affairs and Baroness Hayman of Ullock
• Published: 4 September 2024

Documents

Permit for use of Syvazul BTV3 bluetongue serotype 3 vaccine in the UK

PDF, 90.8 KB, 2 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email defra.helpline@defra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

Defra’s Secretary of State has permitted the use of 3 bluetongue serotype 3 (BTV-3) vaccines within the United Kingdom, subject to licence. Available licences will either be geographically targeted general licences, or specific licences which can be applied for through APHA. General licencing will be subject to risk assessment.

Unlike other BTV vaccines, the currently available BTV-3 vaccines are suppressive, not preventative. This means that they will not prevent your animals from being infected or infectious, although they may reduce the clinical signs experienced. For this reason, all movement controls and trade restrictions in place will still apply to vaccinated animals.

Contact your private veterinarian if you want to use any of the available BTV-3 vaccines.

Published 4 September 2024